This is not investment advice. The author has no position in any of the stocks mentioned. Wccftech.com has a disclosure and ethics policy.

Citron Research's Andrew Left is going after Palantir with the kind of discipline and singleminded focus that is certainly admirable, if a tad too aggressive. After all, the seemingly indomitable short-seller has just tripled down on his $40 per share price target for the high-flying stock.

While speaking on Fox Business recently, Citron Research's Andrew Left had boldly declared that he was now short on Palantir, and that he added to his bearish bet on the stock in the aftermath of Palantir's latest quarterly earnings release, going so far as to label his negative thesis on the stock as "obvious.

Then, earlier this week, Left doubled down on h

See Full Page